Evofem Biosciences, Inc.
EVFM
$0.01
$0.002.67%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.63M | 899.00K | 9.56M | 4.95M | 4.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.63M | 899.00K | 9.56M | 4.95M | 4.83M |
| Cost of Revenue | 511.00K | 410.00K | 2.59M | 905.00K | 755.00K |
| Gross Profit | 2.12M | 489.00K | 6.97M | 4.05M | 4.07M |
| SG&A Expenses | 3.90M | 4.47M | 3.16M | 4.48M | 4.47M |
| Depreciation & Amortization | 14.00K | 75.00K | 89.00K | 80.00K | 107.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.12M | 5.47M | 6.22M | 5.93M | 6.08M |
| Operating Income | -2.49M | -4.57M | 3.35M | -982.00K | -1.25M |
| Income Before Tax | -11.04M | -5.47M | 2.79M | -1.57M | -1.78M |
| Income Tax Expenses | -- | -1.00K | -1.00K | -4.00K | 7.00K |
| Earnings from Continuing Operations | -11.04M | -5.47M | 2.79M | -1.57M | -1.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.04M | -5.47M | 2.79M | -1.57M | -1.78M |
| EBIT | -2.49M | -4.57M | 3.35M | -982.00K | -1.25M |
| EBITDA | -2.47M | -4.49M | 3.44M | -898.00K | -1.14M |
| EPS Basic | -0.08 | -0.04 | 0.02 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.04 | -0.03 | 0.01 | -0.02 | -0.01 |
| EPS Diluted | -0.08 | -0.04 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.04 | -0.03 | 0.00 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 137.34M | 133.25M | 145.94M | 119.58M | 120.49M |
| Average Diluted Shares Outstanding | 137.34M | 133.25M | 25.34B | 119.58M | 120.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |